SLLN-15
SLLN-15 is a potent, selective, and orally bioavailable small molecule that induces cytostatic autophagy. It has demonstrated efficacy in activating macroautophagy in triple-negative breast cancer (TNBC) models, supporting its investigation in both in vitro and in vivo oncology research.
Product Specifications
CAS Number
2403650-93-9
Field of Research
Cell Biology
Smiles
N (C1=C2C (=NC (NC3=CC=C (C=C3) N4CC[Se]CC4) =N1) N=CN2) [C@H]5CC[Se]C5
Molecular Formula
C19H23N7Se2
Molecular Weight
507.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1347750-01 0.02 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype Ia GMP reductase (guaC)
Sign In for Pricing
View Details MBS1347750-02 0.02 mg (Yeast)
Recombinant Streptococcus agalactiae serotype Ia GMP reductase (guaC)
Sign In for Pricing
View Details MBS1347750-03 0.1 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype Ia GMP reductase (guaC)
Sign In for Pricing
View Details MBS1347750-04 0.1 mg (Yeast)
Recombinant Streptococcus agalactiae serotype Ia GMP reductase (guaC)
Sign In for Pricing
View Details MBS1347750-05 0.02 mg (Baculovirus)
Recombinant Streptococcus agalactiae serotype Ia GMP reductase (guaC)
Sign In for Pricing
View Details